0001562180-18-004209.txt : 20181010
0001562180-18-004209.hdr.sgml : 20181010
20181010173940
ACCESSION NUMBER: 0001562180-18-004209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181008
FILED AS OF DATE: 20181010
DATE AS OF CHANGE: 20181010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HILLEMAN JERYL L
CENTRAL INDEX KEY: 0001216628
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 181116790
MAIL ADDRESS:
STREET 1: C/O INTERSECT ENT, INC.
STREET 2: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-10-08
false
0001271214
Intersect ENT, Inc.
XENT
0001216628
HILLEMAN JERYL L
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
Chief Financial Officer
Common Stock
2018-10-08
4
M
false
8167.00
11.12
A
31599.00
D
Common Stock
2018-10-08
4
M
false
4666.00
13.05
A
36265.00
D
Common Stock
2018-10-08
4
S
false
12833.00
27.9945
D
23432.00
D
Stock Option (right to buy)
13.05
2018-10-08
4
M
false
4666.00
0.00
D
2027-01-17
Common Stock
4666.00
65334.00
D
Stock Option (right to buy)
11.12
2018-10-08
4
M
false
8167.00
0.00
D
2024-06-10
Common Stock
8167.00
0.00
D
Includes 20,500 Restricted Stock Units.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.81 to $28.24, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The vesting commencement date of the option is January 1, 2017. 12.5% of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.
The shares subject to the option vest commencing June 4, 2014. 25% of the shares subject to the option vested on June 4, 2015 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years.
/s/ Jeryl L. Hilleman
2018-10-10